8.2 Neonatal Jaundice, Sepsis & Common Disorders

8.2 Neonatal Jaundice, Sepsis & Common Disorders

Core Clinical Rule: Every infant who develops clinical jaundice within the first 24 hours of life must be treated as having a hemolytic or infectious emergency until proven otherwise. In neonatal sepsis, hypothermia is far more common and dangerous than high fever. When prescribing antibiotics for a neonate under 28 days of life, never prescribe Ceftriaxone—it displaces bilirubin from albumin, precipitating lethal kernicterus, and crystallizes with intravenous calcium solutions, producing fatal renal and pulmonary precipitation.

Neonatal jaundice and neonatal sepsis are the two most frequent medical diagnoses encountered in neonatal units and pediatric wards across Kenya. Timely clinical diagnosis, proper laboratory risk stratification, and rigorous adherence to national antimicrobial protocols are paramount to prevent irreversible disability (choreoathetoid cerebral palsy, sensorineural deafness, cretinism) and neonatal mortality.

---

1. Neonatal Jaundice (Hyperbilirubinemia)

Bilirubin Metabolism in the Neonate

Neonates produce bilirubin at more than double the adult rate (8–10 mg/kg/day vs 3–4 mg/kg/day) due to a higher circulating red blood cell (RBC) mass (hematocrit 50–65%) and a shortened RBC lifespan (60–90 days compared to 120 days in adults). Senescent RBCs are degraded by the reticuloendothelial system into biliverdin and then into unconjugated (indirect) bilirubin. This unconjugated form is lipid-soluble, highly neurotoxic, and circulates bound reversibly to serum albumin.

In the liver, unconjugated bilirubin is taken up by hepatocytes and conjugated by the microsomal enzyme uridine diphosphate glucuronosyltransferase (UGT1A1) into water-soluble conjugated (direct) bilirubin, which is excreted through bile into the gut. In the neonatal intestine, high levels of the mucosal enzyme beta-glucuronidase deconjugate bilirubin back into its lipid-soluble unconjugated form, where it is reabsorbed back into the portal circulation—a process known as enterohepatic circulation.

                   [RBC Breakdown (Fetal Hb, Lifespan 60-90 Days)]
                                         │
                                         ▼
                  [Lipid-Soluble Unconjugated (Indirect) Bilirubin]
                           (Bound to Serum Albumin)
                                         │
                                         ▼
                        [Hepatic Uptake via Ligandins]
                                         │
                                         ▼
                 [Conjugation via Hepatic UGT1A1 Glucuronyl Transferase]
                                         │
                                         ▼
                    [Water-Soluble Conjugated (Direct) Bilirubin]
                           (Excreted in Bile to Gut)
                                         │
                                         ▼
                 [Intestinal Deconjugation via Beta-Glucuronidase]
                                         │
                     ┌───────────────────┴───────────────────┐
                     ▼                                       ▼
        [Enterohepatic Recirculation]               [Fecal Excretion]
         (Reabsorbed into portal blood)               (Stercobilin)

Physiological versus Pathological Jaundice

Differentiating physiological from pathological jaundice is one of the most critical clinical competencies required in primary neonatal care:

Etiological Differential by Time of Onset

• Onset < 24 Hours of Life:
  • ABO Blood Group Incompatibility: Mother has blood group O; infant has blood group A or B. Naturally occurring maternal IgG anti-A or anti-B antibodies cross the placenta and lyse fetal RBCs. Direct Coombs (antiglobulin) test is frequently positive (or weakly positive).
  • Rhesus (Rh) Isoimmunization: Mother is Rh-negative (D-negative); infant is Rh-positive (D-positive). Sensitization occurs during previous pregnancy or miscarriages. Results in severe hemolysis, profound fetal anemia, hepatosplenomegaly, and hydrops fetalis. Direct Coombs test is strongly positive.
  • Congenital / Intrauterine Infections (TORCH): Toxoplasmosis, Cytomegalovirus, Rubella, Herpes, Syphilis.
• Onset 24 Hours to 72 Hours of Life:
  • Physiological jaundice:
  • Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency: X-linked recessive enzymopathy common in western Kenya and coastal regions. Acute hemolytic episodes triggered by exposure to oxidant stressors (naphthalene mothballs in baby clothes, maternal ingestion of fava beans, antimalarials, infections).
  • Extravasated Blood: Cephalohematoma, subgaleal hemorrhage, extensive bruising.
  • Polycythemia: Delayed cord clamping, twin-to-twin transfusion, maternal diabetes.
  • Breastfeeding Jaundice (Lack of Milk Jaundice): Occurs in days 2–4 due to inadequate caloric intake, dehydration, infrequent feeding, and delayed meconium passage, resulting in exaggerated enterohepatic recirculation.
• Onset > 72 Hours or Prolonged Jaundice (> 14 Days):
  • Breast Milk Jaundice: Occurs in healthy, thriving breastfed infants due to substances in breast milk (e.g., beta-glucuronidase, non-esterified free fatty acids) that inhibit UGT1A1. Begins after day 4, peaks at week 2–3, and can persist for up to 3 to 12 weeks. Unconjugated, benign, infant gains weight; breastfeeding should continue.
  • Neonatal Sepsis / Urinary Tract Infection:
  • Congenital Hypothyroidism:
  • Biliary Atresia: Progressive inflammatory obliteration of extrahepatic bile ducts. Characterized by conjugated hyperbilirubinemia, dark yellow/tea-colored urine, and pale, clay-colored (acholic) stools. Requires urgent Kasai portoenterostomy before 60 days of life to prevent irreversible biliary cirrhosis and liver failure.

---

2. Kernicterus (Acute Bilirubin Encephalopathy)

Pathophysiology

When circulating total serum bilirubin exceeds the albumin-binding capacity (or when acidosis, hypoxia, hypoalbuminemia, or sepsis disrupt the blood-brain barrier), free, unbound, lipid-soluble unconjugated bilirubin crosses the blood-brain barrier. It binds selectively to lipids and deposits in the basal ganglia (especially the globus pallidus and subthalamic nuclei), the hippocampus, oculomotor nuclei, and brainstem auditory centers. Bilirubin neurotoxicity inhibits mitochondrial enzymes, disrupts protein synthesis, and precipitates neuronal apoptosis and necrosis.

Clinical Phases of Acute Bilirubin Encephalopathy (ABE)

1. Early Phase: Lethargy, generalized hypotonia, sluggish or absent Moro reflex, diminished suckling, and high-pitched cry. Changes are potentially reversible if intensive phototherapy or exchange transfusion is started immediately.
2. Intermediate Phase: Moderate stupor alternating with irritability, hypertonia of extensor muscles, retrocollis (spasmodic backward arching of the neck), opisthotonos (severe backward arching of the trunk), fever, high-pitched shrill cry. Emerging brain injury.
3. Advanced Phase (Established Kernicterus): Pronounced retrocollis and opisthotonos, bicycling limb movements, intractable seizures, upward gaze palsy (setting-sun sign), irregular respirations, coma, and death from respiratory arrest.
4. Chronic Post-Kernicterus Sequelae (Survivors):
   • Choreoathetoid cerebral palsy (involuntary twisting movements)
   • Sensorineural hearing loss (auditory neuropathy spectrum disorder)
   • Vertical upward gaze paralysis (Parinaud syndrome-like)
   • Dental enamel dysplasia of primary deciduous teeth
   • Cognitive and intellectual impairment

Management of Hyperbilirubinemia

+-----------------------------------------------------------------------------------------+
|                        PHOTOTHERAPY PROTOCOL SPECIFICATIONS                             |
+-------------------+---------------------------------------------------------------------+
| **Light Spectrum**| High-intensity blue-green light: wavelength **460 to 490 nanometers**.  |
+-------------------+---------------------------------------------------------------------+
| **Mechanism**     | **Structural Photoisomerization:** Converts toxic lipophilic            |
|                   | 4Z,15Z-bilirubin into water-soluble **lumirubin**, which is rapidly     |
|                   | excreted directly into bile and urine without requiring hepatic         |
|                   | glucuronidation. Also causes configurational photoisomerization.        |
+-------------------+---------------------------------------------------------------------+
| **Eye & Gonadal** | Cover eyes with **opaque eye shields/patches** (prevent retinal         |
| **Protection**    | damage); keep patches clean and inspect eyes daily. Cover genitalia with|
|                   | a minimal diaper to maximize exposed skin surface area.                 |
+-------------------+---------------------------------------------------------------------+
| **Hydration &**   | Encourage frequent breastfeeding (every 2–3 hours); add 10–20% extra    |
| **Temperature**   | fluid volume for increased transepidermal water loss. Turn baby every   |
|                   | 2 to 3 hours. Monitor axillary temperature every 4 hours.               |
+-------------------+---------------------------------------------------------------------+

• Double-Volume Exchange Transfusion (DVET): Indicated when total serum bilirubin reaches critical exchange transfusion cutoffs on gestational age nomograms, or whenever clinical signs of intermediate/advanced acute bilirubin encephalopathy develop regardless of bilirubin level. Replaces twice the infant's circulating blood volume (160 to 170 mL/kg in term infants; 80–85 mL/kg single blood volume x 2) using fresh whole blood (cross-matched against mother and infant). Removes circulating unconjugated bilirubin, clears maternal antibodies, and replaces sensitized, antibody-coated erythrocytes.

---

3. Neonatal Sepsis: Classification, Diagnosis & Treatment

Neonatal sepsis is defined as a systemic bacterial, viral, or fungal infection occurring within the first 28 days of life, accompanied by hemodynamic instability and clinical signs of systemic inflammation.

Early-Onset Sepsis (EOS) versus Late-Onset Sepsis (LOS)

Clinical Manifestations: Subtle Red Flags

Neonates have immature immune systems and cannot localize infections, presenting with subtle, non-specific signs:

• Thermal Instability: Hypothermia (temperature < 36.5°C or < 36.0°C) is far more common, sensitive, and dangerous in Kenyan settings than hyperthermia (temperature > 37.5°C).
• Respiratory Distress: Tachypnea (respiratory rate > 60 bpm), expiratory grunting, severe subcostal and intercostal retractions, cyanosis, and recurrent apnea (> 20 seconds with bradycardia).
• Neurological Depression: Lethargy, somnolence, weak or high-pitched cry, generalized hypotonia, irritability, bulging anterior fontanelle, convulsions.
• Gastrointestinal Dysfunction: Inability to suck or feed, vomiting (frequently bilious), abdominal distension, absent bowel sounds, feed intolerance with large gastric aspirates.
• Hemodynamic / Cutaneous Signs: Delayed capillary refill time (> 3 seconds), tachycardia (> 160 bpm) or bradycardia (< 100 bpm), cold extremities, skin mottling, petechiae, purpura, and sclerema neonatorum (woody induration and hardening of skin and subcutaneous adipose tissue, associated with > 80% mortality).

Diagnostic Investigations (Full Sepsis Screen)

1. Blood Culture: The diagnostic gold standard; collect 0.5–1.0 mL of blood under strict aseptic technique prior to starting antibiotics.
2. Complete Blood Count (CBC / Full Hemogram):
   • Leukopenia (WBC < 5,000/mm³) is significantly more predictive of neonatal sepsis than leukocytosis (WBC > 25,000/mm³).
   • Immature-to-Total Neutrophil (I:T) Ratio > 0.2 (presence of bands, myelocytes, metamyelocytes).
   • Thrombocytopenia (platelets < 100,000/mm³) indicates disseminated sepsis or DIC.
3. C-Reactive Protein (CRP) & Procalcitonin: Serial CRP > 10 mg/L measured 12 to 24 hours after birth.
4. Lumbar Puncture (LP): Mandatory in all suspected neonatal sepsis cases unless the neonate is too hemodynamically unstable. Up to 30% of bacteremic neonates harbor concomitant bacterial meningitis without signs of nuchal rigidity.
5. Chest X-ray: Reticulogranular opacities, lobar consolidation, or diffuse patchy infiltrates.

Kenyan National Antimicrobial Treatment Protocol

+-----------------------------------------------------------------------------------------+
|                 KENYA MOH EMPIRICAL ANTIMICROBIAL REGIMEN FOR NEONATAL SEPSIS           |
+-----------------------+----------------------+--------------------+---------------------+
| ANTIMICROBIAL AGENT   | CLINICAL DOSE        | ROUTE & FREQUENCY  | TARGET SPECTRUM     |
+-----------------------+----------------------+--------------------+---------------------+
| **IV Ampicillin**     | **50 mg/kg / dose**  | IV every **12 hours**| *Listeria*, *GBS*,  |
|                       | (100 mg/kg if        | (q8h if >7 days old| *Enterococcus*,     |
|                       |  meningitis confirmed| in term infants)   | Gram-positives      |
+-----------------------+----------------------+--------------------+---------------------+
| **IV Gentamicin**     | **5 mg/kg / dose**   | IV every **24 hours**| *E. coli*,          |
|                       |                      | (**once daily**)   | *Klebsiella*,       |
|                       |                      |                    | Gram-negative rods  |
+-----------------------+----------------------+--------------------+---------------------+
| *Second-Line /        | IV Cefotaxime        | IV every 12 hours  | Extended-spectrum   |
| *Hospital-Acquired:*  | 50 mg/kg / dose PLUS | (q8h if >7 days)   | Gram-negatives &    |
|                       | IV Flucloxacillin    | IV every 8–12 hours| *S. aureus* (MSSA)  |
|                       | 25–50 mg/kg / dose   |                    |                     |
+-----------------------+----------------------+--------------------+---------------------+

[!CAUTION] Black Box Warning — Ceftriaxone Contraindication in Neonates: Ceftriaxone is strictly contraindicated in all infants under 28 days of life. Ceftriaxone potently displaces unconjugated bilirubin from albumin binding sites, sharply precipitating acute bilirubin encephalopathy (kernicterus). Furthermore, when co-administered with calcium-containing intravenous infusions (such as Ringer's lactate or parenteral nutrition), it forms insoluble, life-threatening calcium-ceftriaxone precipitates that lodge in neonatal lungs and kidneys. When a third-generation cephalosporin is required for neonatal gram-negative meningitis, Cefotaxime must be utilized.

---

4. Congenital Hypothyroidism

Congenital hypothyroidism is one of the most common preventable causes of severe intellectual disability, occurring in 1 in 3,000 to 4,000 live births. In over 85% of cases, it results from thyroid dysgenesis (agenesis, hypoplasia, or ectopic lingual thyroid).

Clinical Presentation

Most neonates appear completely normal at birth because maternal thyroxine (T4) crosses the placenta in small amounts during gestation. However, as maternal T4 wanes over the first several weeks of life, classic clinical features emerge:

• Prolonged Unconjugated Neonatal Jaundice: Persisting beyond 14 days of life due to delayed maturation of hepatic glucuronyl transferase.
• Craniofacial Signs: Large, open anterior fontanelle with widely patent posterior fontanelle (> 5 mm); coarse facial features, puffy eyelids, and macroglossia (large protruding tongue causing feeding difficulties and noisy breathing).
• Voice Changes: Low-pitched, hoarse, guttural cry.
• Abdominal Features: Protuberant abdomen with a large umbilical hernia and stubborn, severe constipation.
• Neuromuscular Signs: Severe generalized hypotonia ('rag-doll / floppy baby'), extreme lethargy, slow feeding, somnolence, and hypothermia with cool, mottled, dry extremities.

Diagnosis and Life-Saving Management

• Laboratory Confirmation: Serum Thyroid-Stimulating Hormone (TSH) is markedly elevated (> 20–40 mIU/L), and serum free thyroxine (Free T4) is low or undetectable.
• Urgent Pharmacotherapy: Initiate oral Levothyroxine (L-T4) at 10 to 15 mcg/kg/day as a single daily dose immediately. The tablet should be crushed and mixed with a few drops of expressed breast milk or sterile water (never with soy formula, calcium, or iron, which impede absorption). Treatment must begin within the first 2 weeks of life to ensure normal brain myelination and prevent permanent cretinism (severe cognitive deficit, dwarfism, sensorineural deafness, and gait ataxia).